Next 10 |
2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...
2024-03-28 12:39:10 ET Read the full article on Seeking Alpha For further details see: NXST, GNTX, and COKE among the best mid-cap technical ideas - Roth MKM
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its first-quarter 2024 results prior to the call. A l...
2024-03-20 10:54:39 ET More on LivaNova PLC LivaNova: Reaching End Of RECOVER And ANTHEM LivaNova PLC Non-GAAP EPS of $0.87 beats by $0.10, revenue of $310.1M beats by $22.4M LivaNova names Vladimir Makatsaria as CEO Read the full article on Seeking Alpha ...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation , has achieved a positive predictive outcome and will conclude enrollment earlier than anticipated...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the pricing of $300 million aggregate principal amount of 2.50% convertible senior notes due 2029 (the “notes”) to be issued in a private offering only to persons reasonably believed to be qual...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its intention to offer $300 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private offering only to persons reasonably believed to be qualified insti...
2024-02-21 10:36:02 ET LivaNova PLC (LIVN) Q4 2023 Earnings Conference Call February 21, 2024 08:00 A.M. ET Company Participants Matthew Dodds - SVP, Corporate Development & IT William Cozy - Chairman and Interim CEO Alex Shvartsburg - CFO Stephanie Bolto...
2024-02-21 06:01:43 ET More on LivaNova PLC LivaNova: Reaching End Of RECOVER And ANTHEM LivaNova names Vladimir Makatsaria as CEO LivaNova to wind down Advanced Circulatory Support business unit Seeking Alpha’s Quant Rating on LivaNova PLC His...
Vimeo Inc. (VMEO) is expected to report $-0.01 for Q4 2023 Heineken N.V ADR (HEINY) is expected to report for Q4 2023 American States Water Company (AWR) is expected to report $0.53 for Q4 2023 NextPlay Technologies Inc. (NXTP) is expected to report for Q3 2024 Inseego Corp. (INSG...
News, Short Squeeze, Breakout and More Instantly...
LivaNova PLC Company Name:
LIVN Stock Symbol:
NASDAQ Market:
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its first-quarter 2024 results prior to the call. A l...
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday. Shares of Sportradar Group AG (NASDAQ: SRAD) rose sharply durin...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation , has achieved a positive predictive outcome and will conclude enrollment earlier than anticipated...